Diagnostic Test Accuracy Protocol
PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer
Editorial Group: Cochrane Lung Cancer Group
Published Online: 7 DEC 2011
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Schmidt-Hansen M, Baldwin DR, Collins E, Zamora J, Abraira V. PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 12. Art. No.: CD009519. DOI: 10.1002/14651858.CD009519.
- Publication Status: New
- Published Online: 7 DEC 2011
This is the protocol for a review and there is no abstract. The objectives are as follows:
To examine the accuracy of integrated PET-CT for mediastinal staging of patients with suspected or confirmed NSCLC which is potentially suitable for treatment with curative intent.
To assess potential sources of heterogeneity including study design (e.g. retrospective/prospective, consecutive/random series), patient populations (number and characteristics, e.g. T- and N-stage, significant nodes on prior CT, country), different cut-off values for test positivity (malignancy), differences in PET-CT image acquisition and/or scanning equipment and potential differences in reference standard (mediastinoscopy/pathological or surgical staging).
See 'Secondary objectives'.